Quantitative and qualitative characterization of Two PD-L1 clones: SP263 and E1L3N

被引：0

作者：

Jacquelyn Smith

Mark D. Robida

Krista Acosta

Bharathi Vennapusa

Amita Mistry

Greg Martin

Alton Yates

H. James Hnatyszyn

机构：

[1] Ventana Medical Systems Inc.,Companion Diagnostics Pharma Services, Assay Development

[2] Roche Tissue Diagnostics,Companion Diagnostics Pharma Services, Pathology Office

[3] Ventana Medical Systems Inc.,Companion Diagnostics, Project Management Office

[4] Roche Tissue Diagnostics,Companion Diagnostics, Pharma Services, Clinical Services Management

[5] Ventana Medical Systems Inc.,Companion Diagnostics Pharma Services, CDx CAP/CLIA Lab Operations

[6] Roche Tissue Diagnostics,undefined

[7] Ventana Medical Systems Inc.,undefined

[8] Roche Tissue Diagnostics,undefined

[9] Ventana Medical Systems Inc.,undefined

[10] Roche Tissue Diagnostics,undefined

来源：

Diagnostic Pathology | / 11卷

关键词：

PD-L1; IHC; NSCLC; SP263; E1L3N;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma But Overall Low Percentage Agreement With Other PD-L1 Clones SP263 and 22C3
Pang, Jia-Min B.
Castles, Belinda
Byrne, David J.
Button, Peter
Hendry, Shona
Lakhani, Sunil R.
Sivasubramaniam, Vanathi
Cooper, Wendy A.
Armes, Jane
Millar, Ewan K. A.
Raymond, Wendy
Roberts-Thomson, Samuel
Kumar, Beena
Burr, Marian
Selinger, Christina
Harvey, Kate
Chan, Charles
Beith, Jane
Clouston, David
O'Toole, Sandra A.
Fox, Stephen B.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2021, 45 (08) : 1108 - 1117
[32] Assessment of PD-L1 Expression in Tumor Microenvironment of Mismatch Repair Deficient Colon Cancer: Comparing Two Antibody Clones, SP142 vs. SP263
Chen, Zongming E.
Bitting, Angela
Lin, Fan
LABORATORY INVESTIGATION, 2017, 97 : 165A - 165A
[33] Assessment of PD-L1 Expression in Tumor Microenvironment of Mismatch Repair Deficient Colon Cancer: Comparing Two Antibody Clones, SP142 vs. SP263
Chen, Zongming E.
Bitting, Angela
Lin, Fan
MODERN PATHOLOGY, 2017, 30 : 165A - 165A
[34] VENTANA anti-PD-L1 (SP263) rabbit monoclonal antibody: A high specificity and sensitivity anti-human PD-L1 antibody
Quon, Chenglu
Xia, Xiaoling
Smith, Margaret
Drace, Colene
Mistry, Amita
Nielsen, Alma
Sabalos, Costi
Towne, Penny
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[35] Evaluation of NSCLC Cytology Cell Block Specimens Using Ventana PD-L1 SP263 Immunohistochemistry Assay
Chauhan, Aastha
Racila, Emilian
Stewart, Jimmie
Amin, Khalid
LABORATORY INVESTIGATION, 2019, 99
[36] Evaluation of NSCLC Cytology Cell Block Specimens Using Ventana PD-L1 SP263 Immunohistochemistry Assay
Chauhan, Aastha
Racila, Emilian
Stewart, Jimmie
Amin, Khalid
MODERN PATHOLOGY, 2019, 32
[37] A comprehensive pan-cancer analysis of PD-L1 expression using clone E1L3N in Chinese patients with cancer
Lu, Huangbin
Huang, Zhan
Ge, Huijuan
Wang, Hongyu
Ruan, Li
Zheng, Frank
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[38] PD-L1 Expression (SP263) in Lung Cancer and Paired Brain Metastases - A Single Center Study in 211 Patients
Kundig, A.
Fung, C.
Scherz, A.
Ochsenbein, A.
Herrmann, E.
Ermis, E.
Schmid, R.
Hewer, E.
Berezowska, S.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S440 - S440
[39] Evaluation of PD-L1 expression in various formalin-fixed paraffin embedded tumour tissue samples using SP263, SP142 and QR1 antibody clones
Kubelka-Sabit, K.
Jashar, D.
Filipovski, V.
Kondeva, M.
VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S307 - S307
[40] Validation of E1L3N antibody for PD-L1 detection and prediction of pembrolizumab response in non-small-cell lung cancer
Song, Lianxi
Zeng, Liang
Yan, Huan
Xu, Qinqin
Xia, Qing
Lei, Jian
Chen, Xiaoyan
Hu, Xiaoping
Wang, Zhan
Liu, Hong
Yang, Nong
Zhang, Yongchang
COMMUNICATIONS MEDICINE, 2022, 2 (01):

← 1 2 3 4 5 →